<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <title>ScreamLine</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link href="/ScreamLine/img/favicon.png" rel="icon">
    <link rel="stylesheet" href="/ScreamLine/css/style.css">
    <link href="/ScreamLine/lib/owlcarousel/assets/owl.carousel.min.css" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;500;700;900&display=swap" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.0/css/all.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
</head>
</head>
<body>
    <div id="header"></div>
    <div class="container-fluid">
        <div class="container">
            <nav class="breadcrumb bg-transparent m-0 p-0">
                <a class="breadcrumb-item text-danger" href="/ScreamLine/index.html">Home</a>
                <a class="breadcrumb-item text-danger" href="#">Category</a>
                <a class="breadcrumb-item text-danger" href="/ScreamLine/scifi.html">Sci-Fi</a>
            </nav>
        </div>
    </div>

    <div class="container-fluid py-3">
        <div class="container">
            <div class="row">
                <div class="col-lg-8">
                    <div class="position-relative mb-3">
                        <img class="img-fluid w-100" src="/ScreamLine/img/scifi/https___www_sciencenews_org_article_brain-cancer-glioblastom.jpg" style="object-fit: cover;">
                        <div class="overlay position-relative bg-light">
                            <div class="mb-3">
                                <a href="" class="text-danger">Science</a>
                                <span class="px-1">/</span>
                                <span>October 24, 2025</span>
                            </div>
                            <div>
                                <h3 class="mb-3">Brain cancer can dissolve parts of the skull</h3>
                                <div class="hero"><p class='important'><strong>Summary:</strong> Glioblastoma, the most aggressive primary brain tumor, is not confined to the cerebral parenchyma. Recent studies reveal that it actively dissolves portions of the skull by hijacking bone‑resorbing pathways, while simultaneously reshaping the immune landscape of the skull marrow. These dual processes complicate surgical resection, influence postoperative recovery, and open new avenues for targeted therapies.</p>

<section>
  <h4>Bone Erosion Mechanisms</h4>
  <p>Glioblastoma cells secrete a cocktail of matrix‑degrading enzymes—chiefly matrix metalloproteinases (MMP‑2, MMP‑9) and cathepsins—that break down the collagenous matrix of cortical bone. The tumor also releases osteoclast‑activating factors such as RANKL and interleukin‑6, tipping the balance toward bone resorption. High‑resolution CT and PET imaging now routinely detect “bony halo” lesions that precede overt skull defects, underscoring the importance of early bone‑preservation strategies during resection.</p>
</section>

<section>
  <h4>Impact on Skull Marrow</h4>
  <p>The skull’s diploic marrow is a unique immunological niche. Tumor‑induced osteoclastic activity releases calcium and other bone‑derived signals that recruit myeloid progenitors, skewing the marrow toward a pro‑tumor phenotype. Scans of resected specimens show a marked reduction in lymphoid follicles and an influx of macrophage‑like cells that express PD‑L1, suggesting that the tumor creates an immune‑suppressive microenvironment even outside the brain.</p>
</section>

<section>
  <h4>Immune Cell Alterations</h4>
  <p>Single‑cell RNA sequencing of skull marrow from glioblastoma patients reveals a dramatic shift: conventional dendritic cells are depleted, while neutrophil‑derived granulocytic myeloid‑derived suppressor cells (G-MDSCs) expand. These cells produce reactive oxygen species that blunt T‑cell function, facilitating tumor escape. The altered cytokine milieu—elevated IL‑10, TGF‑β, and VEGF—further dampens local immunity, creating a sanctuary for tumor cells that may seed the brain after surgery.</p>
</section>

<section>
  <h4>Clinical Implications</h4>
  <p>Skull erosion complicates neurosurgical planning by increasing the risk of intra‑operative bleeding and postoperative infection. Surgeons now routinely incorporate intra‑operative imaging to map bone integrity and use bone‑preserving agents such as bisphosphonates or denosumab to stabilize the skull. Moreover, the immune changes in the marrow suggest that adjunctive immunotherapies—particularly checkpoint inhibitors or macrophage re‑programming agents—could be tailored to target the tumor’s pericranial niche.</p>
</section>

<section>
  <h4>Future Research Directions</h4>
  <p>Ongoing trials are testing the efficacy of combining bone‑resorption inhibitors with CAR‑T cell therapy directed at EGFRvIII, a glioblastoma‑specific antigen. Parallel studies aim to map the temporal evolution of skull marrow immune cells using longitudinal biopsies, hoping to identify biomarkers that predict recurrence. Ultimately, a deeper understanding of how glioblastoma manipulates bone and immune biology may pave the way for multi‑modal treatments that address both the brain tumor and its extracranial accompaniments.</p>
</section></div>
                            </div>
                        </div>
                    </div>
                    <div id="bottom-news"></div>
                </div>
                <div class="col-lg-4" id="sidebar"></div>
            </div>
        </div>
    </div>

    <div id="footer"></div>
    <a href="#" class="btn btn-dark back-to-top"><i class="fa fa-angle-up"></i></a>

    <script src="https://code.jquery.com/jquery-3.4.1.min.js"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.4.1/js/bootstrap.bundle.min.js"></script>
    <script src="/ScreamLine/lib/easing/easing.min.js"></script>
    <script src="/ScreamLine/lib/owlcarousel/owl.carousel.min.js"></script>
    <script src="/ScreamLine/mail/jqBootstrapValidation.min.js"></script>
    <script src="/ScreamLine/mail/contact.js"></script>
    <script src="/ScreamLine/js/main.js"></script>
    <script src="/ScreamLine/js/load-templates.js"></script>
</body>
</html>